Purchase Order HHSN275201700384P

The National Center for Advancing Translational Sciences issued a delivery order to Organix Chemistry Solutions LLC on September 28, 2020, with a ceiling value of $3.674 million, under the master IDIQ for CRO Support for NCATS Medicinal Chemistry for Lead Optimization. The order calls for synthetic chemistry support services to the Therapeutics Development Branch Medicinal Chemistry Team on a cost-no-fee basis. Place of performance is Woburn, MA. The period of performance ran from September...

The Office of Naval Research awarded a purchase order to Richman Chemical, Inc. on February 11, 2026, with a ceiling value of $197,060.00 for synthesis of two specialized organic compounds: (diphenylsilanediyl)bis(ethane-2,1-diyl) bis(5-hydroxypentyl) bis(carbonate) (Compound-A) and (diphenylsilanediyl)bis(propane-3,1-diyl) bis(5-hydroxypentyl) bis(carbonate) (Compound-B). Work is performed in Washington, DC. The order carries no small business set-aside and is priced on a firm fixed price...

This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Patheon API Services, Inc. (doing business as Irix) on February 2, 2012. The contract, valued at $89,900.00, requires the production of 8 kilograms of SGS742 under current good manufacturing practice (CGMP) conditions. The contract has no set-aside designation and is scheduled for completion on April 15, 2012. Patheon API Services, Inc. is the prime contractor, and there is...

The National Cancer Institute awarded a $42,941.42 delivery order to Alchem Laboratories Corporation for the non-Good Manufacturing Practice (non-GMP) synthesis of 100 grams of (R)-N-(6-chloro-4-((1-phenylethyl)amino)pyrido[3,4-d]pyrimidin-5-yl)methanesulfonamide (MTX-531), a small molecule compound. The contract was awarded on July 22, 2022, with an ultimate completion date of October 21, 2022, under a cost-plus-fixed-fee pricing structure. This award was designated as a Total Small Business...

Sri International has been awarded a $1,000 delivery order against the CRO Support for NCATS Medicinal Chemistry for Lead Optimization master IDIQ contract by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences. The delivery order is for a conference call to kick off contract activities in support of the Center's medicinal chemistry programs for lead optimization. The delivery order has a firm fixed price, is to be...

This purchase order contract was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Curia Global Inc. (doing business as Amri) for $79,400. The contract is for X-ray crystallography studies of ALDH1A2 to crystallize two novel small molecules within the enzyme to assist with structure-based drug design as part of an ongoing medicinal chemistry campaign. Specifically, the contractor will perform X-ray crystallography...

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 12, 2026, for Sunosi (suvorexant) 75 mg tablets, 30-count packages, with a ceiling value of $2,736.30 under firm fixed-price terms.</p> <p>Place of performance is Conshohocken, PA. The ultimate completion date is March 13, 2026. No set-aside applied to this order.</p>

Chemogenics Biopharma, LLC has been awarded a $23,540 firm fixed price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences to evaluate the pharmacokinetics of aldometanib in mice. Under the non-competitive contract, Chemogenics will determine aldometanib concentrations in various tissues through synthesis of the compound following a multistep sequence and analytical methods to analyze aldometanib levels. The company will also report and...

Cayman Chemical Co Inc., a specialized biochemical manufacturer based in Ann Arbor, Michigan, has been awarded a $230,365 firm fixed-price purchase order by the Drug Enforcement Administration (DEA) for the synthesis of drug substances. The contract, awarded on January 22, 2026, with an ultimate completion date of August 31, 2026, follows the company's response to a DEA Aviation Division Sources Sought notice issued in late December 2025. The opportunity sought vendors capable of providing...

This federal contract award is for &quot;CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NCGC00413972 FOR PRECLINICAL SAFETY EVALUATION AND CLINICAL TRIAL&quot; and was issued to Curia Global Inc., doing business as Amri. The contract, valued at $907,791.77, is a delivery order under the &quot;CRO Support for NCATS Drug Substance Development and Manufacture&quot; indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. The National Center for Advancing Translational...